These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35795307)

  • 1. Increased monocyte level is a risk factor for radiological progression in patients with early fibrotic interstitial lung abnormality.
    Achaiah A; Lyon P; Fraser E; Saunders P; Hoyles R; Benamore R; Ho LP
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35795307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy.
    García Mullor MM; Arenas-Jiménez JJ; Ureña Vacas A; Gayá García-Manso I; Pérez Pérez JL; Serra Serra N; García Sevila R
    Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S10-S23. PubMed ID: 38642956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival.
    Chae KJ; Chung MJ; Jin GY; Song YJ; An AR; Choi H; Goo JM
    Eur Radiol; 2022 Apr; 32(4):2713-2723. PubMed ID: 34984519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases-Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score.
    Shao G; Hawle P; Akbari K; Horner A; Hintenberger R; Kaiser B; Lamprecht B; Lang D
    Front Med (Lausanne); 2022; 9():1043720. PubMed ID: 36465895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study.
    Hino T; Hida T; Nishino M; Lu J; Putman RK; Gudmundsson EF; Hata A; Araki T; Valtchinov VI; Honda O; Yanagawa M; Yamada Y; Kamitani T; Jinzaki M; Tomiyama N; Ishigami K; Honda H; San Jose Estepar R; Washko GR; Johkoh T; Christiani DC; Lynch DA; Gudnason V; Gudmundsson G; Hunninghake GM; Hatabu H
    Eur J Radiol Open; 2021; 8():100334. PubMed ID: 33748349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up of Interstitial Lung Abnormality: Implication in Follow-Up Strategy and Risk Thresholds.
    Park S; Choe J; Hwang HJ; Noh HN; Jung YJ; Lee JB; Do KH; Chae EJ; Seo JB
    Am J Respir Crit Care Med; 2023 Oct; 208(8):858-867. PubMed ID: 37590877
    [No Abstract]   [Full Text] [Related]  

  • 7. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
    Jin GY; Lynch D; Chawla A; Garg K; Tammemagi MC; Sahin H; Misumi S; Kwon KS
    Radiology; 2013 Aug; 268(2):563-71. PubMed ID: 23513242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
    Lee JE; Chae KJ; Suh YJ; Jeong WG; Lee T; Kim YH; Jin GY; Jeong YJ
    Radiology; 2023 Feb; 306(2):e221172. PubMed ID: 36219115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
    Hunninghake GM; Goldin JG; Kadoch MA; Kropski JA; Rosas IO; Wells AU; Yadav R; Lazarus HM; Abtin FG; Corte TJ; de Andrade JA; Johannson KA; Kolb MR; Lynch DA; Oldham JM; Spagnolo P; Strek ME; Tomassetti S; Washko GR; White ES;
    Chest; 2022 Feb; 161(2):470-482. PubMed ID: 34197782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traction Bronchiectasis/Bronchiolectasis on CT Scans in Relationship to Clinical Outcomes and Mortality: The COPDGene Study.
    Hata A; Hino T; Putman RK; Yanagawa M; Hida T; Menon AA; Honda O; Yamada Y; Nishino M; Araki T; Valtchinov VI; Jinzaki M; Honda H; Ishigami K; Johkoh T; Tomiyama N; Christiani DC; Lynch DA; San José Estépar R; Washko GR; Cho MH; Silverman EK; Hunninghake GM; Hatabu H;
    Radiology; 2022 Sep; 304(3):694-701. PubMed ID: 35638925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.
    Mackintosh JA; Marshall HM; Slaughter R; Reddy T; Yang IA; Bowman RV; Fong KM
    Intern Med J; 2019 Jul; 49(7):843-849. PubMed ID: 30350396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality.
    Hida T; Nishino M; Hino T; Lu J; Putman RK; Gudmundsson EF; Araki T; Valtchinov VI; Honda O; Yanagawa M; Yamada Y; Hata A; Jinzaki M; Tomiyama N; Honda H; Estepar RSJ; Washko GR; Johkoh T; Christiani DC; Lynch DA; Gudnason V; Gudmundsson G; Hunninghake GM; Hatabu H
    Eur J Radiol; 2020 Aug; 129():109073. PubMed ID: 32480316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic Progression of Interstitial Lung Abnormalities following Surgical Resection in Patients with Lung Cancer.
    Shin YJ; Yi JG; Kim MY; Son D; Ahn SY
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of interstitial lung abnormalities in middle-aged never-smokers.
    Pesonen I; Johansson F; Johnsson Å; Blomberg A; Boijsen M; Brandberg J; Cederlund K; Egesten A; Emilsson ÖI; Engvall JE; Frølich A; Hagström E; Lindberg E; Malinovschi A; Stenfors N; Swahn E; Tanash H; Themudo R; Torén K; Vanfleteren LEGW; Wollmer P; Zaigham S; Östgren CJ; Sköld CM
    ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37753274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Incidental Abnormalities on Screening Thoracic Computed Tomography and Mortality: A Long-Term Follow-Up Analysis.
    Lee JE; Jeong WG; Lee HJ; Kim YH; Chae KJ; Jeong YJ
    Korean J Radiol; 2022 Oct; 23(10):998-1008. PubMed ID: 36175001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center.
    Escalon JG; Podolanczuk AJ; Aronson KI; Legasto AC; Gruden JF; Lynch DA; Rachid L; Rabkova Y; Steinberger S
    Clin Imaging; 2023 Dec; 104():109996. PubMed ID: 37862912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between interstitial lung abnormality and mortality in patients with esophageal cancer.
    Hata A; Yanagawa M; Miyata T; Hiraoka Y; Shirae M; Ninomiya K; Doi S; Yamagata K; Yoshida Y; Kikuchi N; Ogawa R; Hatabu H; Tomiyama N
    Jpn J Radiol; 2024 Aug; 42(8):841-851. PubMed ID: 38658500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis.
    Hwang J; You S; Lee YJ; Sun JS
    Eur Radiol; 2025 Jan; 35(1):276-288. PubMed ID: 39026064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
    Patel AS; Miller E; Regis SM; Hunninghake GM; Price LL; Gawlik M; McKee AB; Rieger-Christ KM; Pinto-Plata V; Liesching TN; Wald C; Hashim J; McKee BJ; Gazourian L
    Respir Res; 2023 Feb; 24(1):49. PubMed ID: 36782326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial Lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with Lung Cancer.
    Hata A; Hino T; Yanagawa M; Nishino M; Hida T; Hunninghake GM; Tomiyama N; Christiani DC; Hatabu H
    Radiographics; 2022; 42(7):1925-1939. PubMed ID: 36083805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.